Jun 18, 2021

Group Management: Superior compliance in construction

Group Management
mercury
3 min
Group Management’s Steve Cressey on a uniquely collaborative partnership with Mercury Engineering and almost 15 years of compliant construction projects

Group Management Electrical Surveys is a long-standing and vital partner to Mercury Engineering. The company offers an innovative suite of electrical inspection, test and documentation services to ensure compliance in complex major construction projects for many of the UK and EU's leading companies. Utilising in-house cutting-edge solutions and its highly competent and experienced engineers, Group Management provides everything from electrical inspection and testing to thermal imaging surveys, QA/QC management, torque compliance, technical support, DSEAR compliance and electrical installation condition reports.

“No project can achieve handover without the correct documentation and safety critical electrical certification in place,” says Managing Director Steve Cressey. “Our services ensure that project critical documentation and certification can be correctly produced in an efficient, cost effective manner, which makes Group Management an important part of any construction project.” 

Cressey joined the business in 2009, bringing strong and incisive leadership to Group Management, with decades of industry experience giving him a unique understanding of the design through to handover construction process. He has stewarded the business’ partnership with Mercury since its inception and describes it as uniquely collaborative.  

“Our relationship with Mercury Engineering stretches back many years. We partnered with Mercury  on our first Data Centre project together in Watford in 2007, and since then the relationship has gone from strength to strength,” says Cressey.

“The partnership is longstanding, and we’ve built an incredibly strong working relationship. Partnering with Mercury, who are an innovative, cutting-edge technology provider, means we must constantly improve our services offering. We strive to be the best in what we do, and Mercury can trust we will be efficient in delivering on time, on budget, to achieve a successful handover that meets both Mercury’s and the end clients’ future needs.”

Group Management has since successfully completed more than 30 Data Centre projects throughout the EU as Mercury’s preferred electrical compliance partner. The relationship has also seen Group Management partner with Mercury Engineering on four brand-new hospitals in the UK and Ireland, key pharmaceutical projects and a number of commercial and leisure spaces. 

“To ensure the continued success and growth of Group Management we always discuss projects with key clients and their teams, take feedback on the performance of both our business and our individuals, and in turn use that to improve our services,” Cressey says. 

“The professional development of our employees is essential to our success. All our employees are encouraged to continue their education, to further develop their skills through additional training, and that in turn drives better service and a superior product for our clients. We now offer four more services to Mercury than when the partnership began, which has helped spur Group Management’s growth and success within the wider market.”

 

 

Share article

Jul 7, 2021

NVIDIA launches UK’s most powerful supercomputer

Nvidia
AstraZeneca
SuperComputer
AI
2 min
NVIDIA, an American technology company, has launched the Cambridge-1 supercomputer to advance research in AI and healthcare

NVIDIA has launched the most powerful supercomputer in the UK. Named “Cambridge-1”, its purpose is to enable scientists and healthcare experts to use a combination of artificial intelligence (AI) and simulation to accelerate the digital biology revolution and bolster the country’s world-leading life sciences industry.

“Cambridge-1 will empower world-leading researchers in business and academia with the ability to perform their life’s work on the UK’s most powerful supercomputer, unlocking clues to disease and treatments at a scale and speed previously impossible in the U.K.,” said Jensen Huang, Founder and CEO of NVIDIA. 

“The discoveries developed on Cambridge-1 will take shape in the UK, but the impact will be global, driving groundbreaking research that has the potential to benefit millions around the world”, Huang added. 

What projects will Cambridge-1 be used for? 

The supercomputer represents a US$100mn investment by NVIDIA and is involved in several projects. These include developing a deeper understanding of brain diseases like dementia, using AI to design new drugs, and improving the accuracy of finding disease-causing variations in human genomes.

According to a report by Frontier Economics, an economics consulting firm, Cambridge-1 has the potential to create an estimated value of around US$825mn over the next 10 years.

Cambridge-1 brings together decades of NVIDIA’s work in accelerated computing, AI, and life sciences, where NVIDIA Clara and AI frameworks are optimised to take advantage of the entire system for large-scale research. An NVIDIA DGX SuperPOD supercomputing cluster, it ranks among the world’s top 50 fastest computers and is powered by 100% renewable energy, the company claims. 

NVIDIA and AstraZeneca 

NVIDIA’s Cambridge-1 will be used for a project with the pharmaceutical company and COVID-19 vaccine developer, AstraZeneca, which will focus on the use of AI in digital pathology. In digital pathology, significant time and money are spent annotating whole slide images of tissue samples to help the search for new insights. By using unsupervised AI algorithms trained on thousands of images, it is possible to remove the process of annotating while simultaneously finding potential imaging features that correlate with drug response, NVIDIA says. 

“Training AI algorithms on whole slide images is challenging in part due to the size of the images,” said Lindsay Edwards, Vice President of Data Science and AI, Respiratory and Immunology, BioPharmaceuticals R&D at AstraZeneca. 

“Working with NVIDIA on Cambridge-1 enables us to scale our current work and develop new methodologies advancing the use of AI in digital pathology”, he added. 

 

Share article